Cargando...

Platelet gene therapy corrects the hemophilic phenotype in immunocompromised hemophilia A mice transplanted with genetically manipulated human cord blood stem cells

Our previous studies have demonstrated that platelet FVIII (2bF8) gene therapy can improve hemostasis in hemophilia A mice, even in the presence of inhibitory antibodies, but none of our studies has targeted human cells. Here, we evaluated the feasibility for lentivirus (LV)-mediated human platelet...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Shi, Qizhen, Kuether, Erin L., Chen, Yingyu, Schroeder, Jocelyn A., Fahs, Scot A., Montgomery, Robert R.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2014
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3894495/
https://ncbi.nlm.nih.gov/pubmed/24269957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-08-520478
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!